Brief: Laurus Labs Receives USFDA Tentative Approval Of Oral Dispersible Film (Odf) Dolutegravir 5Mg And 10Mg For Pediatric Arv Treatment
02/05/2023 09:17
May 2 (Reuters) - Laurus Labs Ltd LAUL.NS :
* RECEIVES USFDA TENTATIVE APPROVAL OF ORAL DISPERSIBLE FILM
(ODF)
DOLUTEGRAVIR 5MG AND 10MG FOR PEDIATRIC ARV TREATMENT
Source text for Eikon: ID:nBSE8vp2vF
Further company coverage: LAUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig